We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-15.8%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$537M
AUM Growth
-$133M
Cap. Flow
-$47.6M
Cap. Flow %
-8.86%
Top 10 Hldgs %
11.25%
Holding
1,208
New
454
Increased
145
Reduced
142
Closed
463

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$10.5M
2
TFC icon
Truist Financial
TFC
+$8.46M
3
QCOM icon
Qualcomm
QCOM
+$8.04M
4
WBA
Walgreens Boots Alliance
WBA
+$4.59M
5
EOG icon
EOG Resources
EOG
+$4.52M

Sector Composition

Rank Sector Weight
1 Technology 20.77%
2 Healthcare 13.14%
3 Consumer Discretionary 12.35%
4 Industrials 11.65%
5 Financials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
726
Agenus
AGEN
$255M
$31K 0.01%
+805
New +$29.2K
BRFS
727
DELISTED
BRF SA
BRFS
$30K 0.01%
11,700
+1,600
+16% +$4.72K
GOTU icon
728
Gaotu Techedu
GOTU
$374M
$29K 0.01%
+14,861
New +$23.8K
SOPA
729
DELISTED
Society Pass
SOPA
$26K ﹤0.01%
+900
New +$29.6K
LITS
730
Lite Strategy Inc
LITS
$33.2M
$24K ﹤0.01%
+1,960
New +$21.3K
MFG icon
731
Mizuho Financial
MFG
$129B
$24K ﹤0.01%
+10,900
New +$25.7K
PGEN icon
732
Precigen
PGEN
$1.93B
$21K ﹤0.01%
+15,600
New +$23.1K
PRTK
733
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$21K ﹤0.01%
+10,700
New +$23.3K
ROOT icon
734
Root
ROOT
$944M
$20K ﹤0.01%
+950
New +$25.7K
LAB icon
735
Standard BioTools
LAB
$303M
$17K ﹤0.01%
+10,700
New +$26.5K
EAR
736
DELISTED
Eargo, Inc. Common Stock
EAR
$15K ﹤0.01%
+980
New +$46.3K
ZY
737
DELISTED
Zymergen Inc. Common Stock
ZY
$15K ﹤0.01%
12,500
-24,500
-66% -$41.1K
SNDL icon
738
Sundial Growers
SNDL
$351M
$12K ﹤0.01%
+3,620
New +$16K
AFIB
739
DELISTED
Acutus Medical Inc
AFIB
$12K ﹤0.01%
+10,672
New +$9.16K
RUBY
740
DELISTED
Rubius Therapeutics, Inc
RUBY
$12K ﹤0.01%
+14,080
New +$23.6K
PRQR icon
741
ProQR Therapeutics
PRQR
$244M
$10K ﹤0.01%
13,200
-400
-3% -$298
CFMS
742
DELISTED
Conformis, Inc. Common Stock
CFMS
$6K ﹤0.01%
628
QTNT
743
DELISTED
Quotient Limited Ordinary Shares
QTNT
$5K ﹤0.01%
520
-48
-8% -$1.02K
BYU
744
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$3K ﹤0.01%
50
ATHX
745
DELISTED
Athersys, Inc. Common Stock
ATHX
$3K ﹤0.01%
+528
New +$5.84K
AAOI icon
746
Applied Optoelectronics
AAOI
$7.85B
-15,300
Closed -$56K
ABR icon
747
Arbor Realty Trust
ABR
$977M
-14,700
Closed -$251K
ABUS icon
748
Arbutus Biopharma
ABUS
$871M
-12,100
Closed -$36K
ACCO icon
749
Acco Brands
ACCO
$381M
-12,000
Closed -$96K
ACLS icon
750
Axcelis
ACLS
$3.94B
-13,200
Closed -$997K

Similar funds

Bayesian Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bayesian Capital Management held 1,208 positions worth $537M, down 20% from $670M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bayesian Capital Management withdrew a net $47.6M in Q2 2022, closing 463 positions and reducing 142 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $35.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bayesian Capital Management opened a new position in T-Mobile US worth $10.8M.

  • Bayesian Capital Management's largest Q2 2022 buy was T-Mobile US: 80,110 shares worth $10.8M.
  • Bayesian Capital Management added most to iShares Russell 2000 ETF in Q2 2022, an estimated $4.26M increase.
  • Bayesian Capital Management's biggest Q2 2022 reduction was Verizon, cutting an estimated $4.51M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $35.6M.
  • Bayesian Capital Management's ten largest holdings make up 11% of its $537M portfolio in Q2 2022.
  • Bayesian Capital Management opened 454 new positions and closed 463 in Q2 2022.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $537M.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.